|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.480 USD | -8.07% |
|
-6.33% | -25.63% |
| Market Cap | 428M 376M 349M 321M 606M 40.97B 619M 4.16B 1.63B 20.13B 1.61B 1.57B 69.59B | P/E 2026 * |
-1.67x | P/E 2027 * | -2.36x |
|---|---|---|---|---|---|
| Enterprise Value | 389M 342M 317M 291M 550M 37.19B 562M 3.78B 1.48B 18.27B 1.46B 1.43B 63.17B | EV / Sales 2026 * |
3.03x | EV / Sales 2027 * | 2.5x |
| Free-Float |
3.32% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Autolus Therapeutics plc
| 1 day | -8.07% | ||
| 1 week | -6.33% | ||
| Current month | -7.50% | ||
| 1 month | -5.13% | ||
| 3 months | -0.67% | ||
| 6 months | -1.33% | ||
| Current year | -25.63% |
| 1 week | 1.48 | 1.74 | |
| 1 month | 1.46 | 1.74 | |
| Current year | 1.18 | 2.07 | |
| 1 year | 1.18 | 2.7 | |
| 3 years | 1.1 | 7.45 | |
| 5 years | 1.1 | 7.9 | |
| 10 years | 1.1 | 53.24 |
| Manager | Title | Age | Since |
|---|---|---|---|
Martin Pulé
CTO | Chief Tech/Sci/R&D Officer | 53 | 31/08/2014 |
Christian Itin
CEO | Chief Executive Officer | 61 | 29/02/2016 |
Robert Dolski
DFI | Director of Finance/CFO | 56 | 06/08/2023 |
| Director | Title | Age | Since |
|---|---|---|---|
Christian Itin
CHM | Chairman | 61 | 30/09/2014 |
John Berriman
BRD | Director/Board Member | 78 | 31/07/2014 |
Cynthia Butitta
BRD | Director/Board Member | 71 | 28/02/2018 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 06-28 | Free | Director | 79,167 | 0.0477% | ||
| 06-28 | Free | Director | 79,167 | 0.0477% | ||
| 06-28 | Free | Chairman | 79,167 | 0.0477% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -8.07% | -6.33% | -40.08% | -41.04% | 428M | ||
| -0.22% | +1.35% | +16.79% | -7.70% | 67.61B | ||
| -0.63% | -9.21% | +37.82% | +200.20% | 51.6B | ||
| +0.36% | +40.00% | +40.00% | +40.00% | 43B | ||
| -1.26% | -0.39% | -49.63% | -53.84% | 40.94B | ||
| +4.96% | -3.28% | +55.75% | -24.71% | 29.4B | ||
| -1.85% | -15.99% | +99.20% | -46.78% | 27.09B | ||
| -2.12% | -2.25% | +66.54% | +82.33% | 23.32B | ||
| -0.67% | +1.48% | +10.61% | +188.35% | 19.92B | ||
| -2.12% | -3.72% | +61.37% | +126.08% | 16.91B | ||
| Average | -0.89% | -2.77% | +29.84% | +46.29% | 32.02B | |
| Weighted average by Cap. | -0.05% | -3.05% | +30.87% | +47.21% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 129M 113M 105M 96.32M 182M 12.29B 186M 1.25B 488M 6.04B 483M 472M 20.88B | 191M 168M 156M 143M 270M 18.26B 276M 1.85B 725M 8.97B 717M 701M 31.02B |
| Net income | -241M -212M -197M -181M -342M -23.09B -349M -2.35B -917M -11.34B -907M -887M -39.22B | -184M -161M -150M -138M -260M -17.57B -265M -1.78B -698M -8.63B -690M -675M -29.84B |
| Net Debt | -39.53M -34.73M -32.19M -29.62M -55.95M -3.78B -57.13M -384M -150M -1.86B -148M -145M -6.42B | 48.41M 42.53M 39.43M 36.27M 68.52M 4.63B 69.97M 470M 184M 2.27B 182M 178M 7.86B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 13/07/26 | US$1.480 | -8.07% | 2,088,666 |
| 10/07/26 | US$1.610 | -4.73% | 1,348,300 |
| 09/07/26 | US$1.690 | -0.59% | 1,111,045 |
| 08/07/26 | US$1.700 | +5.59% | 1,673,442 |
| 07/07/26 | US$1.610 | -1.23% | 755,323 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.

Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- AUTL Stock
Select your edition
All financial news and data tailored to specific country editions

















